Page 5 - Flipbook

Fred Saad Michael Kolinsky
Professor and Chief of Urology, Director of GU Oncology, Associate Program Director, Medical Oncology Residency

University of Montreal Hospital Center (CHUM) Training, University of Alberta

Disclosures: Disclosures:
Grant/Honorarium: Astellas, Astra Zeneca, Bayer, Novartis, Janssen, Honorarium & Clinical Trials: Astella, AstraZeneca, BMS, Bayer, Eisai,
Myovant, Sanofi Ipsen, Janssen, Merck

Neil Fleshner Anil Kapoor

Chair and Professor, Division of Urology, University of St. Joseph's Healthcare, Institute of Urology
Toronto
Disclosures:

Disclosures: Advisory Boards: Amgen, BMS, Merck, Novartis, Pfizer, Roche, Eisai,
Payment: Astellas, Janssen, AbbVie, Sanofi, Merck / Ipsen, Verity / Grant/Honorarium: Amgen, Novartis, Pfizer / Clinical
Grant/Honorarium: Astellas, Janssen, Bayer / Investments: Verity Trial: Amgen, Novartis, Pfizer, CCTG, BMS, Merck
Pharma / Clinical Trials: Astellas, Janssen, Bayer / Leadership
Position: Point Biopharma

Mike Boivin

Clinical Pharmacist, Consultant, Continuing Education,
CommPharm Consulting Inc.
Planning Committee
Disclosures:
Advisory Boards: SDM, AbbVie, Novo-Nordisk, Emergent BioSolutions,
AstraZeneca / Payment/Honoraria: SDM, AbbVie, Novo-Nordisk,

Emergent BioSolutions, AstraZeneca